191 related articles for article (PubMed ID: 17947731)
21. The clinical impact of antibacterial prophylaxis and cycling antibiotics for febrile neutropenia in a hematological malignancy and transplantation unit.
Craig M; Cumpston AD; Hobbs GR; Devetten MP; Sarwari AR; Ericson SG
Bone Marrow Transplant; 2007 Apr; 39(8):477-82. PubMed ID: 17322937
[TBL] [Abstract][Full Text] [Related]
22. Antibacterial prophylaxis in patients with cancer and neutropenia.
Ito JI; Tegtmeier BR; O'Donnell MR
N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395829
[No Abstract] [Full Text] [Related]
23. Efficacy and safety of moxifloxacin as antibacterial prophylaxis for patients receiving autologous haematopoietic stem cell transplantation: a randomised trial.
Vehreschild JJ; Moritz G; Vehreschild MJ; Arenz D; Mahne M; Bredenfeld H; Chemnitz J; Klein F; Cremer B; Böll B; Kaul I; Wassmer G; Hallek M; Scheid C; Cornely OA
Int J Antimicrob Agents; 2012 Feb; 39(2):130-4. PubMed ID: 22169408
[TBL] [Abstract][Full Text] [Related]
24. Neutropenic events in community practices reduced by first and subsequent cycle pegfilgrastim use.
Ozer H; Mirtsching B; Rader M; Luedke S; Noga SJ; Ding B; Dreiling L
Oncologist; 2007 Apr; 12(4):484-94. PubMed ID: 17470691
[TBL] [Abstract][Full Text] [Related]
25. Modeling the cost effectiveness of secondary febrile neutropenia prophylaxis during standard-dose chemotherapy.
Timmer-Bonte JN; Adang EM; Termeer E; Severens JL; Tjan-Heijnen VC
J Clin Oncol; 2008 Jan; 26(2):290-6. PubMed ID: 18182670
[TBL] [Abstract][Full Text] [Related]
26. Antibacterial prophylaxis in patients with cancer and neutropenia.
Eller P; Pechlaner C
N Engl J Med; 2006 Jan; 354(1):90-4; author reply 90-4. PubMed ID: 16395828
[No Abstract] [Full Text] [Related]
27. The prevention of febrile neutropenia.
Pascoe J; Cullen M
Curr Opin Oncol; 2006 Jul; 18(4):325-9. PubMed ID: 16721125
[TBL] [Abstract][Full Text] [Related]
28. Antibiotic prophylaxis in neutropenic patients: new evidence, practical decisions.
Leibovici L; Paul M; Cullen M; Bucaneve G; Gafter-Gvili A; Fraser A; Kern WV
Cancer; 2006 Oct; 107(8):1743-51. PubMed ID: 16977651
[TBL] [Abstract][Full Text] [Related]
29. Development and implementation of a risk assessment tool for chemotherapy-induced neutropenia.
Donohue R
Oncol Nurs Forum; 2006 Nov; 33(2):347-52. PubMed ID: 16518450
[TBL] [Abstract][Full Text] [Related]
30. Use of antibacterial prophylaxis for patients with neutropenia. Australian Consensus Guidelines 2011 Steering Committee.
Slavin MA; Lingaratnam S; Mileshkin L; Booth DL; Cain MJ; Ritchie DS; Wei A; Thursky KA;
Intern Med J; 2011 Jan; 41(1b):102-9. PubMed ID: 21272174
[TBL] [Abstract][Full Text] [Related]
31. A European Organization for Research and Treatment of Cancer-International Antimicrobial Therapy Group Study of secondary infections in febrile, neutropenic patients with cancer.
Akova M; Paesmans M; Calandra T; Viscoli C;
Clin Infect Dis; 2005 Jan; 40(2):239-45. PubMed ID: 15655741
[TBL] [Abstract][Full Text] [Related]
32. Evaluation of the efficacy of prophylactic intravenous antibiotherapy with ceftriaxone in post-chemotherapy agranulocytic patients.
Pignon B; Thiriet L; Aubert D; Pennaforte JL; Vilque JP; Lartigue B; Jolly D; Bajolet-Laudinat O; Etienne JC
Nouv Rev Fr Hematol (1978); 1990; 32(4):249-52. PubMed ID: 2290711
[TBL] [Abstract][Full Text] [Related]
33. Antibiotic prophylaxis for transrectal prostate biopsy: a prospective randomized study of tosufloxacin versus levofloxacin.
Yamamoto S; Ishitoya S; Segawa T; Kamoto T; Okumura K; Ogawa O
Int J Urol; 2008 Jul; 15(7):604-6. PubMed ID: 18462354
[TBL] [Abstract][Full Text] [Related]
34. Elderly cancer patients receiving chemotherapy benefit from first-cycle pegfilgrastim.
Balducci L; Al-Halawani H; Charu V; Tam J; Shahin S; Dreiling L; Ershler WB
Oncologist; 2007 Dec; 12(12):1416-24. PubMed ID: 18165618
[TBL] [Abstract][Full Text] [Related]
35. Identification of patients at risk for early death after conventional chemotherapy in solid tumours and lymphomas.
Ray-Coquard I; Ghesquière H; Bachelot T; Borg C; Biron P; Sebban C; LeCesne A; Chauvin F; Blay JY;
Br J Cancer; 2001 Sep; 85(6):816-22. PubMed ID: 11556830
[TBL] [Abstract][Full Text] [Related]
36. Onset of symptom resolution in adults with acute bacterial rhinosinusitis treated with a single dose of azithromycin extended release compared with 10 days of levofloxacin: a retrospective analysis of a randomized, double-blind, double-dummy trial.
Marple BF; Roberts CS; de Caprariis PJ; Reisman A
Clin Ther; 2007 Dec; 29(12):2690-8. PubMed ID: 18201585
[TBL] [Abstract][Full Text] [Related]
37. Risk of infection among patients with non-metastatic solid tumors or non-Hodgkin's lymphoma receiving myelosuppressive chemotherapy and antimicrobial prophylaxis in US clinical practice.
Weycker D; Chandler D; Barron R; Xu H; Wu H; Edelsberg J; Lyman GH
J Oncol Pharm Pract; 2017 Jan; 23(1):33-42. PubMed ID: 26568602
[TBL] [Abstract][Full Text] [Related]
38. [A prospective, controlled, non-randomized study of three cohorts to test the effectiveness of two antibiotics levofloxacin and cotrimoxazol on antibacterial prophylaxis in neutropenic patients].
Gracia Escudero A; Martín González M; Giménez Garrido F; Clavero Farré C; García Pérez MJ; Alvarez Corral G; Reyes Bertos A; Villegas Maldonado G; Rodríguez Cuartero A
Med Clin (Barc); 2003 Mar; 120(9):321-5. PubMed ID: 12646106
[TBL] [Abstract][Full Text] [Related]
39. Impact of neutropenia on delivering planned chemotherapy for solid tumours.
Khan S; Dhadda A; Fyfe D; Sundar S
Eur J Cancer Care (Engl); 2008 Jan; 17(1):19-25. PubMed ID: 18181887
[TBL] [Abstract][Full Text] [Related]
40. Levofloxacin prophylaxis to prevent bacterial infection in chemotherapy-induced neutropenia in acute leukemia.
Rahman MM; Khan MA
Bangladesh Med Res Counc Bull; 2009 Dec; 35(3):91-4. PubMed ID: 20922911
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
